Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
nutrimmun is a specialized German healthcare company focused on the development and distribution of high-quality nutritional supplements, particularly in the fields of probiotics and orthomolecular medicine. Based in Münster, the company provides scientifically-backed products designed to support gut health, the immune system, and overall metabolic balance. Their portfolio includes well-established brands such as MucoZink and the Probio-Cult range, which are primarily distributed through pharmacies and recommended by medical professionals. nutrimmun emphasizes a holistic approach to health, combining beneficial bacterial cultures with specific micronutrients to optimize the intestinal environment. The company maintains high quality standards in its formulations, catering to patients with dysbiosis, food intolerances, and immune-related concerns.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on nutrimmun.